BPC-157
5 mg
$41.99 CAD
Synthetic peptide related to thymosin beta-4 · Research reagent
A short thymosin-related peptide studied for its chemical identity. It is distinct from full-length thymosin beta-4.
$109.99 CAD
· $11.00 / mgIn stockSample 5026_0267 · 100.00% purity
PPB Analytical Inc. · View report
In stock · Ships next business day from Toronto
Interac e-Transfer
$9.99 shipping, free from $250 · Ships from Toronto · Canada only
Shipping and returns: Ships next business day from Toronto · $9.99 shipping, free from $250 · Arrives right or we make it right
For research use only. Not for human consumption.
Proof Line vials are filled from Align Biosciences stock under the Proof Line label. This is Align’s independent lab report for TB-500 10 mg. The report records a laboratory sample ID; a production lot number is shown when the report includes one.
TB-500, also published as TB500, is catalogued here as: Synthetic peptide related to thymosin beta-4. Studied analytically to identify the short thymosin-related fragment; molecular identity matters before comparing wound-model literature. TB-500 is a research material whose name is associated with thymosin beta-4 and with a shorter synthetic peptide containing that protein’s actin-binding domain. Which molecular form a given vial contains is a supplier-specified detail that should be confirmed from documentation rather than inferred from the name. A short thymosin-related peptide studied for its chemical identity. It is distinct from full-length thymosin beta-4.
The relevant literature examines actin-binding thymosin biology in wound-repair models, often in animals with impaired healing, because those models make changes in repair easier to detect.
Analytical work identified Ac-LKKTETQ in one TB-500 product and detected the fragment and metabolites in equine samples. Separately, Philp et al. studied thymosin beta-4 and an actin-binding-domain peptide in mice; that related-molecule study does not establish the identity or effects of a TB-500 vial.
Analytical identity literature: Chromatography and mass spectrometry identified Ac-LKKTETQ in the TB-500 product examined in 2012. This identifies that study sample, not PLP’s material or every TB-500 listing.
Analytical identity literature: A separate study detected the fragment and its metabolites in equine samples. An analytical detection study, not evidence of human efficacy; full-length thymosin beta-4 findings cannot be substituted.
Proof Line Peptides lists TB-500 as a vial in 10 mg and 5 mg, with pack sizes of 1, 3, 5 and 10. Prices are shown in Canadian dollars, and orders ship from Toronto by tracked Canadian service.
The matched PPB Analytical Inc. report for TB-500 10 mg (report 2026030628-02, dated Mar. 27, 2026) records 100.00% purity. It documents the supplier sample sent for testing, not every shipped lot, and the original PDF is linked on this page.
Shipped lyophilized (freeze-dried) and stable at room temperature in transit. Store sealed vials in the fridge or freezer on arrival. Once reconstituted, refrigerate. Anything not right? Our guarantee covers it.